Dilon nets CE Mark for gamma camera

Dilon Technologies has received CE Mark approval for the commercial sale of the Dilon 6800 gamma camera in EU member countries.

The Newport News, Va.–based Dilon said its system is a high-resolution gamma camera that enables molecular imaging of the breast and other small organs for early cancer detection.

“The body of clinical evidence related to our camera's performance and ability to detect tumors continues to mount; now medical professionals around the world will have access to the technology,” said Robert Moussa, chairman and CEO, Dilon.

Around the web

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services.